ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 306

The Role of Inflammation in the Evolution of MRI Erosions in the Feet of Patients with Early RA

Hanyan Zou1, Karen A. Beattie2, Saara Totterman3, George Ioannidis1 and Maggie Larche2,4, 1McMaster University, Hamilton, ON, Canada, 2Medicine, McMaster University, Hamilton, ON, Canada, 3Qmetrics Technologies, Pittsford, NY, 4St Joseph's Healthcare Hamilton, Hamilton, ON, Canada

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Inflammation, Magnetic resonance imaging (MRI), rheumatoid arthritis (RA) and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Imaging of Rheumatic Diseases Poster I: MRI

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Patients with aggressive RA develop early structural damage. As persistent inflammation is associated with bone erosions, assessing inflammatory activity may be key in treatment decision-making to slow or prevent further damage. This study aimed to determine the impact of inflammation on US and changes in erosions on MRI in early RA.

Methods: Patients with RA (ACR criteria, treatment naïve, symptom duration <2 years) were recruited and treated as per standard of care. The 2nd-5th metatarsophalangeal joints (MTPJs) were imaged using US (Esaote MyLab70) at study entry, 6 weeks, 3-, 6- and 12-months follow-up. MTPJs were semi-quantitatively graded for synovial thickening (ST) and power Doppler (PD) (0-3, 3=severe inflammation). The most clinically symptomatic foot at baseline was imaged using a 1.0T peripheral MRI (GE Medical) at baseline, 12-months, and at a 24-49 months follow-up. MRI erosions were semi-quantitatively graded using the OMERACT-RAMRIS system (grade 0-10) for the metatarsal heads and phalanx bases. We characterized the number of MTPJs with low (grade <2) or high (grade ≥2) ST or PD during the majority of the first 12 months, and the number of erosions that were unchanged, improved or worsened by grade ≥1 over the follow-up.

Results: Forty-one patients were included [n=33 female, mean (SD) age=51.6 (10.3) years]. Of 32 patients with follow-up MRIs, total erosion score decreased (improved erosions) in 17 patients and increased (worsened) in 18. Ten patients had a simultaneous improvement and worsening of erosions in different MTPJs. At baseline, 12- and ≥24-months, 299, 308 and 242 metatarsal heads and phalanx bases were graded on MRI. Approximately 40% of joints had a grade ≥1 erosion at each visit, and 5-7% had grade ≥2 erosions. Of all baseline erosions, 28% improved and 27% worsened after 12-months; 40% improved and 29% worsened from baseline to post-24 months. Most changes were by grade 1, and the largest change was by grade 2. Joints with persistently low ST scores had more frequent erosion healing and fewer worsened erosions than joints with persistently high ST (Table 1). MTPJs with persistently high ST had more erosions that worsened than improved after 12 months, but approximately the same number had improved and worsened erosions after ≥24 months. Persistently high PD and erosion progression occurred very infrequently. Six patients were not treated with DMARDs or biologics throughout the study duration. Four of these patients had persistently high ST, of whom 3 had worsened total erosion scores.

Conclusion: Our findings suggested that more erosions worsened in joints with persistent severe inflammation than joints with low inflammation in early RA. The value of US inflammation for predicting erosion progression warrants further investigation, especially in populations with greater disease activity.

Table 1: MTPJs with persistently low or high inflammation during the first 12 months, and the progression of their MRI erosions after 12 months and after 24-49 months.

MRI erosion BL to 12 months

MRI erosion BL to post-24 months

ST

PD

Stable

Improve

Worsen

Sum

Stable

Improve

Worsen

Sum

Low

Low

71 (64%)

24 (22%)

16 (14%)

111

53 (55%)

29 (30%)

14 (15%)

96

High

2 (100%)

0

0

2

2 (100%)

0

0

2

High

Low

24 (69%)

3 (9%)

8 (23%)

35

14 (56%)

5 (20%)

6 (24%)

25

High

1 (50%)

0

1 (50%)

2

1 (50%)

0

1 (50%)

2

Sum

98

27

25

150

71

33

21

125


Disclosure: H. Zou, None; K. A. Beattie, None; S. Totterman, Qmetrics Technologies, 4; G. Ioannidis, None; M. Larche, AbbVie Inc., 2.

To cite this abstract in AMA style:

Zou H, Beattie KA, Totterman S, Ioannidis G, Larche M. The Role of Inflammation in the Evolution of MRI Erosions in the Feet of Patients with Early RA [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/the-role-of-inflammation-in-the-evolution-of-mri-erosions-in-the-feet-of-patients-with-early-ra/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-role-of-inflammation-in-the-evolution-of-mri-erosions-in-the-feet-of-patients-with-early-ra/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology